1. Introduction {#sec1}
===============

American ginseng (*Panax quinquefolium* L.) originally grows in southeast of Canada and northern USA, whereas *Panax ginseng* Meyer is commonly referred to ginseng or Korean ginseng. American ginseng and ginseng are of the same Araliaceae and *Panax* genus, present pharmacological activity to reduce stress, enhance immune function and treat several chronic diseases, and so on to improve the quality of life [@bib1], [@bib2], [@bib3], [@bib4]. Ginseng has a "warm" property based on the traditional Chinese medicine theory and American ginseng has a "cool" property. Therefore, the efficacy, pharmacological effects, and clinical indications of these two similar roots are different, and they are suitable for different physique and age groups. Ginseng has two types of popular products by drying and steaming process, named white ginseng and red ginseng, respectively. Compared with white ginseng, the red one seemed to show better bioactivity in some cases. Meanwhile, only dried American ginseng is found available in the commercial market.

Ginsenosides are the major pharmacologically active constituents of *Panax* genus. According to the aglycone skeletons, most are the dammarane triterpene type with protopanaxadiol (PPD) and protopanaxatriol (PPT), oleanane type (OLE) and ocotillol type (OCO) of ginsenosides [@bib4], [@bib5]. Compared to ginseng, the OCOC-type ginsenoside is the characteristic in American ginseng. The ginseng roots also contain ginsenosides with a malonyl or acetyl residue attached to the glucose substituent on C-3 or C-6 position. Ginseng has gained increasing attention in health care; therefore, identification and quantification of the chemical composition of ginseng is necessary for quality, safety, and efficacy control. Many studies of red ginseng have demonstrated that steaming- or heating- or acidic condition-induced ginsenoside structural conversions are significantly related to the biological activities improvement [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11]. And also some informations on ginsenosides in American ginseng processing were reported [@bib12], [@bib13], [@bib14]. Recent studies demonstrated that ginseng presents its efficacy through multi-targeted mechanisms instead of a single chemical constituent influence. Hence, monitoring the chemical components, as many as possible, in red American ginseng processing is important. The structure diversity of ginsenosides are the chemical basis of dried and red American ginseng; they exert different pharmacological activities. During the past few years, many modern techniques have been developed to determine ginsenosides in ginseng. The most commonly used are HPLC-UV [@bib15], HPLC coupled with evaporative light scattering detector [@bib16], [@bib17], HPLC combined with electrospray ionization tandem mass spectrometry (HPLC--ESI--MS^n^) [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], and ultra-performance liquid chromatography/quadrupole time-of-flight MS [@bib24], [@bib25], [@bib26], [@bib27]. The ongoing developments of MS permit high sensitivity, selectivity, resolution, and throughput analysis of traditional Chinese medicine. However, the systematic comparison of ginsenosides and chemical transformations between dried and red American ginseng has not been studied and discussed.

In this paper, HPLC-MS^n^ technique was developed to evaluate the global ginsenosides of dried American ginseng and steaming processed red American ginseng. The 59 main constituents of ginsenosides were identified by combining the complementary fragmentation data for structure confirmation and eluting sequence provided. The relative peak areas of PPD, PPT, OCO, and OLE type components were calculated and compared. Base on the multicomponent assessment approach, the influence of steaming time and temperature on the composition of ginsenosides was determined. The conversions brought about by each type of ginsenosides during steaming process were investigated, and the possible mechanisms were discussed. The validated HPLC-MS^n^ method demonstrated that holistic chemical profiling as characteristic chemical components to assess the quality of American ginseng and standardize the processing procedures of red American ginseng is reasonable and effective.

2. Materials and methods {#sec2}
========================

2.1. Chemicals and reagents {#sec2.1}
---------------------------

Methanol (HPLC grade, Fisher Scientific, Waltham, MA), formic acid (HPLC grade, Sigma-Aldrich, Steinheim, Germany), ultrapure water (18 MΩ/cm, Milli-Q water system, Lillipore, Bedford, MA), methanol (analytical grade, Beijing Chemical Works, Beijing, China), and reference ginsenosides Rb~1~, Rb~2~, Rb~3~, Rc, Rd, Re, Rg~1~, 20(S)-Rg~2~, 20(S)-Rg~3~, 20(S)-Rh~1~, 20(S)-Rh~2~, F~1~, F~2~, Ro, and 20(R)-pseudoginsenoside F~11~ (Jilin University, Changchun, JL, China) were obtained.

2.2. Reference solution preparation {#sec2.2}
-----------------------------------

Reference solutions for 15 ginsenosides were prepared individually by 50% methanol-water to final concentration of 0.1 mg/mL and were diluted with HPLC grade methanol to make desired concentrations for MS^n^ fragmentation analysis. Each of the individual reference solutions were combined and diluted to obtain final concentrations for HPLC-MS retention time analysis.

2.3. Plant materials and sample preparation {#sec2.3}
-------------------------------------------

The 5-year-old fresh *Panax quinquefolium* L. roots were collected from Fusong, Jilin province. The botanical origin was identified by Prof Shumin Wang and deposited at the Jilin Ginseng Academy. The main roots with diameter measuring 1--2 cm were chosen for the process experiment (drying and steaming). The dried American ginseng was prepared under sunlight. The red American ginseng was prepared as following: (1) fresh American ginseng roots were cleaned and allowed to air-dry at room temperature; (2) the roots were placed in an autoclave to steam at 100°C or 120°C for 2 h or 4 h or 6 h, separately; (3) the steamed roots were cooled and then dried in a ventilated oven at 50°C for approximately 2--3 d.

Furthermore, 100 g of each root were powdered using a pulverizer and sieved before extraction to assure the analyzed samples were well-distributed and typical. Ultrasonic-assisted extraction of ginsenosides from the pulverized ginseng roots powder (1.0 g) was performed using 80% methanol-water for 30 min. The extraction was repeated thrice with fresh solvent. Then, the extracts were combined, reduced pressure concentrated, and re-dissolved to 1 mL 80% methanol-water. The supernatant was filtered through a 0.45-μm polyvinylidene fluoride syringe filter and used for direct HPLC-MS^n^ analysis. The extraction of five replicated samples and blank samples was prepared under the same procedure.

2.4. Instrument and condition {#sec2.4}
-----------------------------

HPLC system (Ultimate 3000, Dionex) consists of a quaternary gradient pump, an autosampler, and a thermostatic-column compartment, coupled to linear trap quadrupole (LTQ) linear ion trap mass spectrometer (Thermo Scientific) and controlled with Xcalibur version 3.0 data system software. Thermo Scientific Syncronis C18 HPLC column (100 mm × 2.0 mm, 1.7 μm) was used for separations.

The ESI--MS^n^ was operated under negative ion mode. The data were acquired in centroid scan mode with normal scan rate and *m/z* 150.0--2000.0 scan range. According to standard calibration procedure, the mass scale was calibrated prior to detection. The sheath gas and aux gas were high purity N~2~ with a flow rate of 40 mL/min and 10 mL/min, respectively. The other parameters were set to achieve the best ion signals: electrospray voltage, 3.0 kV; capillary voltage, 20 V; and capillary temperature, 320°C. For the MS^n^ analyses, the isolation width was 1.0 Da, and collision energies ranged from 10% to 30%. The ginsenoside references were analyzed by infusing individual solutions directly to mass spectrometer at 5 μL/min using the syringe pump.

The mobile phases were 0.1% formic acid in acetonitrile (Solvent A) and 0.1% formic acid in ultrapure water (Solvent B). The gradient elution program with 0.2 mL/min flow rate was as follows: 0--10 min held at 10% A, 10--40 min linearly increased to 100% A, 40--50 min held at 100% A, 50--60 min returned to 10% A. The temperatures of autosampler and column were set at 15°C and 35C°, respectively, and the injection volume was 5 μL.

3. Results and discussion {#sec3}
=========================

3.1. Development of HPLC-MS^n^ method {#sec3.1}
-------------------------------------

The LTQ linear ion trap mass spectrometer was applied for determination. First, each ginsenoside solution was analyzed by direct injection in both positive and negative ion modes to check the appropriate ionization mode. The \[M^−^H\]^−^ ion presented higher intensity than \[M+H\]^+^ ion. Thus, the identification and quantification of ginsenosides were carried out in the negative ion mode by ESI-MS^n^ and HPLC-MS^n^. The spray voltage, capillary temperature, S-lens RF level, and flow rates of sheath gas and aux gas were checked manually to obtain the best experimental conditions. To gain maximum sensitivity and highest signal intensity, the other MS parameters were also optimized by tuning each type of ginsenosides (PPD, PPT, OLE and OCO).

After direct MS analysis, HPLC was coupled to the mass spectrometer via the column cell outlet. After several trials, chromatographic conditions were optimized using American ginseng extraction to ensure the appropriate resolution. The composition of mobile phases considerably affects the transference yield of analytes from liquid to gas in MS detection. Formic acid concentrations (0.1%, 0.05%, and 0.01%) were tested; the best peak shape and improved ionization efficiency lead to a significant signal enhancement. The gradient elution program was investigated to ensure acceptable separation of adjacent peaks.

3.2. ESI-MS^n^ and HPLC-ESI-MS analysis of four types of ginsenoside standards {#sec3.2}
------------------------------------------------------------------------------

The structures of four types of ginsenosides (PPD, PPT, OCO, and OLE) are shown in [Fig. 1](#fig1){ref-type="fig"}. The aglycones of ginsenosides with dehydration and addition reaction are also presented in [Fig. 1](#fig1){ref-type="fig"}. In MS full scan under both positive and negative ion mode, the molecular weights of ginsenosides were easily obtained by their quasi-molecular ions. The characteristic fragmentations of each four types of ginsenoside standards were investigated and summarized in [Table 1](#tbl1){ref-type="table"}. According to the specific fragments of each type of ginsenosides, the substituted saccharide chain types and sequence and the aglycone type were determined. The nomenclature for ginsenoside fragmentation is based on the description given by Domon and Costello [@bib28] and Liu et al. [@bib29]. The saccharide substitution at C-20 is α chain, while saccharide substitution at C-3 (PPD) or C-6 (PPT) is β chain [@bib29]. Ions (produced by glycoside cleavages) retaining the charge at the reducing terminus are termed Y and Z, whereas product ions retaining the charge at the non-reducing terminus are termed B and C [@bib28], [@bib29]. Cross-ring cleavages produced ions retaining the charge at the reducing terminus are termed X, and product ions retaining the charge at the non-reducing terminus are termed A, with superscript numbers indicating the two bonds cleavage [@bib28], [@bib29]. Take Rb~1~ and Re as an example, the fragmentation nomenclature of PPD- and PPT-type ginsenosides are shown in [Scheme 1](#sch1){ref-type="fig"}.Fig. 1The aglycone structures of protopanaxadiol, protopanaxatriol, oleanane, and ocotillol types of ginsenosides and their dehydration and hydration addition ginsenosides. OCO, ocotillol; OLE, oleanane; PPD, protopanaxadiol; PPT, protopanaxatriol.Fig. 1Table 1The ginsenosides identified in dried and red American ginseng. Ac, acetyl; Mal, malonylTable 1t~*R*~CompoundsMolecular formulaMolecular mass\[M-H\]^−^MS^n^ fragments19.3120(S)-Rf~2~C~42~H~74~O~14~802.5801.7619(Y~1β~), 145(B~1β~), 493(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)19.9520(R)-Rf~2~C~42~H~74~O~14~802.5801.7619(Y~1β~), 145(B~1β~), 493(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)21.20ReC~48~H~82~O~18~946.6945.7783(Y~0α~), 179(C~1α~), 637(Y′~1β~), 145(B~1β~), 475(Y′~0β~), 307(B~2β~), 101(^2,5^A~1α~/^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)21.22Rg~1~C~42~H~72~O~14~800.5799.8637(Y~0α~), 179(C~1α~), 475(Y′~0β~), 161(B~1β~), 101(^2,5^A~1α~/^2,5^A~1β~)22.56Malonyl-Rg~1~C~45~H~74~O~17~886.5885.6799\[M-H-Mal\]^−^, 637(Y~0α~), 179(C~1α~), 475(Y′~0β~), 161(B~1β~), 101(^2,5^A~1α~/^2,5^A~1β~)22.7624(S)-Pseudo-F~11~C~42~H~72~O~14~800.5799.8653(Y~1β~), 145(B~1β~), 491(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)24.28Compound McC~42~H~72~O~11~752.5751.5621(Y~1α~), 145(C~1α~), 459(Y~0α~), 293(B~2α~), 191(^0,4^A~2α~)26.45Acetyl-Rg~1~C~44~H~74~O~15~842.5841.6799\[M-H-Ac\]^−^, 637(Y~0α~), 179(C~1α~), 475(Y′~0β~), 161(B~1β~), 101(^2,5^A~1α~/^2,5^A~1β~)26.95Pseudo-RT~2~C~41~H~70~O~14~786.5785.6653(Y~1β~), 131(B~1β~), 491(Y~0β~), 293(B~2β~), 191(^1,3^A~2β~), 265(^1,5^A~2β~)27.2924(R)-Pseudo-F~11~C~42~H~72~O~14~800.5799.8653(Y~1β~), 145(B~1β~), 491(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)27.77Pseudo-RT~5~C~36~H~62~O~10~654.4653.8491(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)28.55Rb~1~C~54~H~92~O~23~1108.61107.8945(Y~1α~), 179(C~1α~), 783(Y~0α~), 323(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^0,4^A~2α~/^1,3^A~2β~)28.57Pseudo-F~8~C~55~H~92~O~23~1120.61119.81077\[M-H-Ac\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)29.02Malonyl-Rb~1~C~57~H~94~O~26~1194.61193.81107\[M-H-Mal\]^−^, 945(Y~1α~), 179(C~1α~), 783(Y~0α~), 323(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 191(^0,4^A~2α~), 221(^1,3^A~2β~)29.2120(S)-Rg~2~C~42~H~72~O~13~784.5783.8637(Y~1β~), 145(B~1β~), 475(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)29.48RcC~53~H~90~O~22~1078.61077.7945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)29.5620(R)-Rg~2~C~42~H~72~O~13~784.5783.8637(Y~1β~), 145(B~1β~), 475(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)29.7120(S)-Rh~1~C~36~H~62~O~9~638.4637.9475(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)29.88RoC~48~H~76~O~19~956.5955.9793(Y~0α~/Y~1β~), 631(Y′~1β~), 455(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 119(^0,2^A~1β~), 221(^1,3^A~2β~)29.97Malonyl-RcC~56~H~92~O~25~1164.61163.71077\[M-H-Mal\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)30.30Rb~2~C~53~H~90~O~22~1078.61077.6945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)30.4020(R)-Rh~1~C~36~H~62~O~9~638.4637.8475(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)30.53Rb~3~C~53~H~90~O~22~1078.61077.7945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)30.72Malonyl-Rb~2~C~56~H~92~O~25~1164.61163.61077\[M-H-Mal\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)30.95Malonyl-Rb~3~C~56~H~92~O~25~1164.01163.61077\[M-H-Mal\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)31.22Quinquefolium R~1~C~56~H~94~O~24~1150.51149.71107\[M-H-Ac\]^−^, 945(Y~1α~), 179(C~1α~), 783(Y~0α~), 323(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 191(^0,4^A~2α~), 221(^1,3^A~2β~)31.5224(R)-Vina-R~1~C~44~H~74~O~15~842.5841.6799\[M-H-Ac\]^−^, 653(Y~1β~), 145(B~1β~), 491(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)31.61Pseudo-RT~1~C~47~H~74~O~18~926.5925.8763(Y~0α~), 793(Y~1β~), 631(Y′~1β~), 455(Y′~0β~), 101(^2,5^A~1α~), 105(^0,2^A~1β~), 191(^1,3^A~2β~)32.02F~1~C~36~H~62~O~9~638.4637.8475(Y~0α~), 179(C~1α~), 101(^2,5^A~1α~)32.12Quinquefolium IC~52~H~86~O~19~1014.61013.7945\[M-H-68\]^−^, 783(Y~0α~), 161(B~1α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^1,3^A~2β~)32.13RdC~48~H~82~O~18~946.6945.9783(Y~0α~), 161(B~1α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^1,3^A~2β~)32.45Malonyl-RdC~51~H~84~O~21~1032.61031. 7945\[M-H-Mal\]^−^, 783(Y~0α~), 161(B~1α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^1,3^A~2β~)32.57Chikusetsusaponin IVaC~42~H~66~O~14~794.5793.9631(Y~0α~), 455(Y′~0β~), 101(^2,5^A~1α~), 149(^0,2^A~1β~)32.66Rs~1~C~55~H~92~O~23~1120.61119.31077\[M-H-Ac\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)32.81Rs~2~C~55~H~92~O~23~1120.61119.61077\[M-H-Ac\]^−^, 945(Y~1α~), 149(C~1α~), 783(Y~0α~), 293(B~2α~), 621(Y′~1β~), 459(Y′~0β~), 191(^0,4^A~2α~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)33.0920(S)-acetyl-Rg~2~C~44~H~74~O~14~826.5825.7783\[M-H-Ac\]^−^, 637(Y~1β~), 145(B~1β~), 475(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)33.29Gypenoside X VIIC~48~H~82~O~18~946.6945.7783(Y~1α~), 179(C~1α~), 621(Y~0α~), 323(B~2α~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^0,4^A~2α~)33.3020(R)-acetyl-Rg~2~C~44~H~74~O~14~826.5825.7783\[M-H-Ac\]^−^, 637(Y~1β~), 145(B~1β~), 475(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)33.99Pseudo-RC~1~C~50~H~84~O~19~988.6987.8945\[M-H-Ac\]^−^, 783(Y~0α~), 161(B~1α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^1,3^A~2β~)34.64Quinquefolium IIIC~50~H~84~O~19~988.6987.7945\[M-H-Ac\]^−^, 783(Y~0α~), 161(B~1α~), 621(Y′~1β~), 459(Y′~0β~), 101(^2,5^A~1α~/^2,5^A~1β~), 221(^1,3^A~2β~)35.11Rg~6~C~42~H~70~O~12~766.5765.9619(Y~1β~), 145(B~1β~), 457(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)35.44Rg~4~C~42~H~70~O~12~766.5765.8619(Y~1β~), 145(B~1β~), 457(Y~0β~), 307(B~2β~), 101(^0,2^A~1β~), 205(^1,3^A~2β~), 279(^1,5^A~2β~)35.69F~2~C~42~H~72~O~13~784.5783.5621(Y~0α~), 161(B~1α~), 459(Y′~0β~), 101(^2,5^A~1α~)35.96Rk~3~C~36~H~60~O~8~620.4619.9457(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)36.05Zingibroside R~1~C~42~H~66~O~14~794.5793.9631(Y~1β~), 455(Y~0β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)36.37Rh~4~C~36~H~60~O~8~620.4619.9457(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)36.8120(S)-Rg~3~C~42~H~72~O~13~784.5783.8621(Y~1β~), 179(C~1β~), 459(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)37.0120(R)-Rg~3~C~42~H~72~O~13~784.5783.8621(Y~1β~), 179(C~1β~), 459(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)38.6220(S)-Rs~3~C~44~H~74~O~14~826.5825.9783\[M-H-Ac\]^−^, 621(Y~1β~), 179(C~1β~), 459(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)38.78Calenduloside EC~36~H~56~O~9~632.4631.8455(Y~0β~), 149(^0,2^A~1β~)38.8520(R)-Rs~3~C~44~H~74~O~14~826.5825.9783\[M-H-Ac\]^−^, 621(Y~1β~), 179(C~1β~), 459(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)39.72Rk~1~C~42~H~70~O~12~766.5765.5603(Y~1β~), 161(B~1β~), 441(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)40.04Rg~5~C~42~H~70~O~12~766.5765.5603(Y~1β~), 161(B~1β~), 441(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)41.1620(S)-Rh~2~C~36~H~62~O~8~622.4621.7459(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)41.4220(R)-Rh~2~C~36~H~62~O~8~622.4621.7459(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)41.77Rs~5~C~44~H~72~O~13~808.5807.6765\[M-H-Ac\]^−^, 603(Y~1β~), 161(B~1β~), 441(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)42.08Rs~4~C~44~H~72~O~13~808.5807.6765\[M-H-Ac\]^−^, 603(Y~1β~), 161(B~1β~), 441(Y~0β~), 323(B~2β~), 101(^2,5^A~1β~), 221(^1,3^A~2β~)46.25Rk~2~C~36~H~60~O~7~604.5603.4441(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)46.52Rh~3~C~36~H~60~O~7~604.5603.4441(Y~0β~), 161(B~1β~), 101(^2,5^A~1β~)Scheme 1The fragmentation nomenclature of protopanaxadiol and protopanaxatriol types of ginsenosides Rb~1~ and Re.Scheme 1

For PPD-type ginsenoside Rb~1~, the Y~1α~ ion at *m/z* 945 is generated by loss of a glucose residue (162 Da). And the C~1α~ ion at *m/z* 179 is also demonstrated that the terminal residue in an α saccharide chain at C-20 of Rb~1~ is glucose residue. The Y~0α~ ion at *m/z* 783 is corresponding to the loss of glucose-glucose residue (162 Da + 162 Da). And the B~2α~ ion at *m/z* 323 provides further information for glucose-glucose linkage. The Y′~1β~ ion at *m/z* 621 is produced by the loss of glucose-glucose residue (162 Da + 162 Da) at α saccharide chain and glucose residue (162 Da) at β saccharide chain. The Y′~0β~ ion at *m/z* 459 is generated by the loss of glucose-glucose residue (162 Da + 162 Da) at α saccharide chain and glucose-glucose residue (162 Da + 162 Da) at β saccharide chain. The *m/z* 101 (^2,5^A~1α~/^2,5^A~1β~) ion and *m/z* 221 (^0,4^A~2α~/^1,3^A~2β~) ion are corresponding to the cross-ring cleavage products of glucose and glucose-glucose terminals at α or β saccharide chains. According to the other authentic PPD-type ginsenoside standards (Rb~2~, Rb~3~, Rc, Rd, 20(S)-Rg~3~, 20(S)-Rh~2~, F~2~) fragmentation pathway, the *m/z* 459 ion is the typical aglycone of PPD-type ginsenosides. The specific neutral monosaccharide residue losses are 162 Da, 146 Da, and 132 Da corresponding to glucose, rhamnose, and arabinose or xylose substitutions, respectively.

For PPT-type ginsenoside Re, the Y~0α~ ion at *m/z* 783 is generated by the loss of a glucose residue (162 Da). And the C~1α~ ion at *m/z* 179 is also demonstrated that the terminal residue in an α saccharide chain at C-20 of Re is glucose residue. The Y′~1β~ ion at *m/z* 637 is produced by the loss of glucose residue (162 Da) at α saccharide chain and rhamnose residue (146 Da) at β saccharide chain. And the B~1β~ ion at *m/z* 145 provides further information for rhamnose residue at β saccharide r chain. The Y′~0β~ ion at *m/z* 475 is generated by the loss of glucose residue (162 Da) at α saccharide chain and rhamnose-glucose residue (146 Da + 162 Da) at β saccharide chain. And the B~2β~ ion at *m/z* 307 also provides further information for rhamnose-glucose residue at β saccharide chain. The *m/z* 101 (^2,5^A~1α~/^0,2^A~1β~) ion, *m/z* 205 (^1,3^A~2β~) ion, and *m/z* 279 (^1,5^A~2β~) ion are corresponding to the cross-ring cleavage products of glucose and rhamnose-glucose terminals at α or β saccharide chains. According to the other authentic PPT-type ginsenoside standards (Rg~1~, 20(S)-Rg~2~, 20(S)-Rh~1~, F~1~) fragmentation pathway, the *m/z* 475 ion is the characteristic aglycone of PPT-type ginsenosides. The specific neutral saccharide residue losses are 162 Da, 132 Da, and 146 Da corresponding to glucose, rhamnose, and arabinose or xylose substitutions, respectively.

For OCO-type pseudoginsenoside F~11~, the Y~1β~ ion at *m/z* 653 is produced by the loss of rhamnose residue (146 Da) at β saccharide chain. And the B~1β~ ion at *m/z* 145 provides further information for rhamnose residue at β saccharide chain. The Y~0β~ ion at *m/z* 491 is generated by the loss of rhamnose-glucose residue (146 Da + 162 Da) at β saccharide chain; it is the characteristic aglycone of OCO type ginsenosides. And the B~2β~ ion at *m/z* 307 also provides further information for rhamnose-glucose residue at β saccharide chain. The *m/z* 101 (^0,2^A~1β~) ion, *m/z* 205 (^1,3^A~2β~) ion, and *m/z* 279 (^1,5^A~2β~) ion are corresponding to the cross-ring cleavage products of glucose and rhamnose-glucose terminals at β saccharide chain.

For the OLE-type ginsenoside Ro, the fragment ion at *m/z* 793 (Y~0α~/Y~1β~) is generated by the loss of a glucose residue (162 Da) in α or β saccharide chain. The Y′~1β~ ion at *m/z* 631 is produced by the loss of glucose residue (162 Da) at α saccharide chain and glucose residue (162 Da) at β saccharide chain. The Y′~0β~ ion at *m/z* 455 is produced by losing glucose residue (162 Da) at α saccharide chain and glucose-glucose residue (162 Da + 162 Da) at β saccharide chain; it is the characteristic aglycone of OLE-type ginsenosides. The *m/z* 101 (^2,5^A~1α~/^2,5^A~1β~) ion, *m/z* 119 (^0,2^A~1β~) ion and *m/z* 221 (^1,3^A~2β~) ion are corresponding to the cross-ring cleavage products of glucose and glucose-glucose terminals at α or β saccharide chains.

Composite 15 ginsenosides standards were analyzed by HPLC-ESI-MS for retention time determination. The molecular weights, fragmentation patterns, and retention times were useful for identification of ginsenoside structures in complex mixtures.

3.3. Ginsenoside profiling of dried and red American ginseng {#sec3.3}
------------------------------------------------------------

The ginsenoside profiling of dried and red American ginseng extracts were analyzed by HPLC-ESI-MS^n^ to determine the retention time, molecular weight information, aglycone type, and saccharide substitution sequences according to characteristic fragmentation. [Fig. 2](#fig2){ref-type="fig"} showed the HPLC-MS total ion chromatogram (TIC) in the negative ion mode of the ginsenosides of dried and red American Ginseng (100°C and 120°C) extracts. Approximately 59 major ginsenosides were investigated, 15 of which were unambiguous identified by comparison of retention times, molecular weight, and specific fragmentations with standards. The other peaks of TIC were tentatively identified by matching the molecular weight with the reported information of known ginsenosides and further verified by characteristic fragment pathways to provide structural information for the elucidation of results. The detailed identifications of components are listed in [Table 1](#tbl1){ref-type="table"}. As the ginsenosides presented similar polarity and isomerization, the appropriate chromatographic gradient and extracted ion chromatogram were applied to analyze the overlapped and isomeric peaks.Fig. 2The HPLC-MS total ion chromatogram of the ginsenosides extracts of (A) dried American Ginseng; (B) red American Ginseng (100°C for 2 h); and (C) red American Ginseng (120°C for 6 h) in the negative ion mode.Fig. 2

The observation of *m/z* 459 fragment ion provided evidence of PPD-type aglycone ginsenosides\' presence. Within this group, \[M-H\]^−^ ion at *m/z* 1107 (Rb~1~), 1077 (Rb~2~, Rb~3~, Rc), 945 (Rd), 783 (20(S)-Rg~3~, F~2~), 621 (20(S)-Rh~2~) were identified by comparison with retention time and specific fragment ions of ginsenoside references. Due to the unavailability of 20(R) epimer references, 20(R)-Rg~3~ and 20(R)-Rh~2~ were distinguished with their 20(S) epimers on the basis of their chromatographic behavior, as the 20(S) epimer was reported to elute earlier than its 20(R) epimer. Malonylated and acetylated ginsenosides were detected as characteristic fragments \[M-malonyl\]^--^ or \[M-acetyl\]^--^ by the loss of 86 Da or 42 Da in MS^2^. And in MS^n^ experiment, the observed fragment ions accorded with their corresponding neutral ginsenosides. Some peaks showed PPD-type aglycone with dehydration at *m/z* 441, which is △20(21)- or △20(22)-dehydrated-PPD specific ion. And △20(21)-isomers were reported to elute earlier than its △20(22)-isomers. Therefore, peaks at *m/z* 765 (Rk~1~, Rg~5~) and 603 (Rk~2~, Rh~3~) were identified.

For the peaks presented, *m/z* 475 fragment ions were classified as PPT-type ginsenosides, as shown in [Table 1](#tbl1){ref-type="table"}. The specific ion at *m/z* 493 and 457 yielded from PPT aglycone ion (*m/z* 475) with +18 Da and −18 Da mass differences and corresponded to the addition and dehydration reaction occurrence in C-20 side chain of PPT. Therefore, 24,25-hydrated-PPT, △20(21)- and △20(22)-dehydrated-PPT observed in MS^n^ were identified as 20(S,R)-Rf~2~, Rk~3~ and Rh~4~, respectively. Malonylated and acetylated ginsenosides with characteristic loss of 86 Da or 42 Da were also detected. A total of 17 major PPT-type ginsenosides were identified from the extracts of dried and red American ginseng. There were five OCO-type ginsenosides detected in the extracts of American ginseng. According to the specific fragment at *m/z* 491 and saccharide chain composition and position, structural characterizations were obtained. Similarly, another five OLE-type ginsenosides were identified ([Table 1](#tbl1){ref-type="table"}).

3.4. Effects of steaming time and temperature on ginsenosides composition in red American ginseng {#sec3.4}
-------------------------------------------------------------------------------------------------

The holistic chemical profiles of dried and red American ginseng were systematically compared by qualitative and quantitative analysis. The ginsenoside composition differences between dried and red American ginseng, steamed at 100°C or 120°C for 2 h or 4 h or 6 h are shown in [Table 2](#tbl2){ref-type="table"}. The effects of steaming time and temperature on the ginsenoside chemical conversion during processing were investigated. As shown in [Table 2](#tbl2){ref-type="table"}, the relative peak areas of 59 ginsenosides were calculated by the area ratios of individual peak to total peaks. As the malonyl and acetyl ginsenosides were rather unstable, the relative peak areas of this kind of ginsenosides decreased sharply to undetectable levels with the increasing of steaming time or temperature. Compared to dried American ginseng, the relative peak areas of Rb~1~, Rb~2~, and so on increased rapidly at 100°C for 2 h, indicating that the malonyl and acetyl ginsenosides degraded to their corresponding neutral ginsenosides. And then Rb~1~, Rb~2~, Rb~3~, Rc, Rd, Rg~1~, Re decreased gradually during steaming. After steaming at 120°C for 6 h, Rb~1~, Rb~2~, Rb~3~, Rc, Rd, Rg~1~, Re levels were much lower. A number of ginsenoside products increased gradually. Meanwhile, some newly formed ginsenosides among them were identified as 20(R,S)-Rf~2~, 20(R)-Rh~1~, 20(R)-Rh~2~, Rh~3~, Rh~4~, Rk~1~, Rk~2~, Rk~3~, 20(R)-Rg~2~, 20(R)-Rg~3~, Rg~4~, Rg~5~, Rg~6~. For OCO- and OLE-type ginsenosides, pseudoginsenoside F~11~ and Ro decreased sharply after steaming for 6 h at 120°C. Correspondingly, newly converted pseudoginsenoside RT~5~, Chikusetsusaponin IVa, Zingibroside R~1~, and Calenduloside E were identified and relatively quantified.Table 2The relative peak areas of HPLC-MS total ion chromatogram of ginsenosides in dried and red American ginseng steamed at 100°C or 120°C for 2 h or 4 h or 6 h. AG, American ginseng; nd, not detectedTable 2Compoundsdried AGred AG100°C\
2 h100°C 4 h100°C\
6 h120°C\
2 h120°C\
4 h120°C\
6 hRb~1~9.4923.2422.6020.4521.039.921.04Rb~2~0.181.030.880.840.880.220.03Rb~3~1.931.601.541.441.470.400.05Rc7.565.424.534.324.771.070.10Rd20.1714.1812.8610.5111.947.542.14Gypenoside X VII2.151.761.461.200.690.520.12Compound Mcndndndndnd0.010.0120(S)-Rg~3~0.051.983.384.583.638.179.5720(R)-Rg~3~nd1.362.253.422.607.199.54F~2~0.240.180.220.120.070.080.0720(S)-Rh~2~ndndndndnd0.010.0520(R)-Rh~2~ndndndndnd0.010.04Rk~1~nd0.621.191.681.313.684.32Rg~5~nd0.671.361.841.443.864.35Rk~2~ndndndndndndndRh~3~ndndndndndndndMalonyl-Rb~1~12.402.85ndndndndndMalonyl-Rb~2~0.560.06ndndndndndMalonyl-Rb~3~0.690.03ndndndndndMalonyl-Rc1.380.23ndndndndndMalonyl-Rd9.681.20ndndndndndQuinquefolium R~1~6.925.835.624.904.402.630.25Pseudo-F~8~0.570.080.070.060.060.040.02Rs~1~0.130.090.080.070.080.030.01Rs~2~0.290.120.110.100.110.040.01Pseudo-RC~1~8.532.382.031.432.071.460.51Quinquefolium III2.940.330.290.210.240.210.1220(S)-Rs~3~nd2.591.490.410.350.270.1520(R)-Rs~3~nd0.080.140.260.201.042.00Rs~4~nd0.010.050.070.060.290.50Rs~5~nd0.010.060.080.080.390.69Quinquefolium I0.540.390.370.330.360.240.09Re31.9216.5716.0314.7214.043.310.14Rg~1~1.631.180.650.530.650.230.2120(S)-Rg~2~2.472.044.094.803.259.3010.8120(R)-Rg~2~nd1.132.553.242.078.0811.51F~1~nd0.000.010.010.010.020.0320(S)-Rf~2~nd0.000.020.040.020.351.0220(R)-Rf~2~nd0.000.010.030.010.311.43Rg~6~nd0.791.832.081.435.718.37Rg~4~0.041.092.472.761.916.8810.0820(S)-Rh~1~0.010.050.150.170.240.461.0920(R)-Rh~1~nd0.030.090.110.160.421.38Rk~3~nd0.020.040.050.080.210.72Rh~4~nd0.020.060.070.110.300.99Malonyl-Rg~1~2.06ndndndndndndAcetyl-Rg~1~1.240.01ndndndndnd20(S)-acetyl-Rg~2~0.050.010.020.020.020.060.2020(R)-acetyl-Rg~2~ndndndndnd0.050.17Ro14.577.924.593.856.235.892.82Pseudo-RT~1~1.920.920.800.641.000.790.11Chikusetsusaponin IVa2.002.091.761.311.602.622.93Zingibroside R~1~0.840.380.220.290.201.010.82Calenduloside E0.100.130.220.310.210.280.4024(S)-Pseudo-F~11~0.680.280.260.200.250.200.1824(R)-Pseudo-F~11~12.294.085.802.753.875.394.68Pseudo-RT~2~3.461.941.250.781.631.440.02Pseudo-RT~5~nd0.010.020.040.050.100.5724(R)-Vina-R~1~0.210.160.090.050.080.020.01

The results indicated that malonyl and acetyl ginsenosides with high molecular weights are characteristic constituents of dried American ginseng. The neutral and high molecular weight ginsenosides are major components of red American ginseng (100°C), while rare ginsenosides with low molecular weight and less polarity form specific composition of red American ginseng (120°C). Similar results were obtained in ginseng and notoginseng steaming. In our work, the acetyl rare ginsenosides (Rs~3~, Rs~4~, and Rs~5~) were only detected in red American ginseng (100°C and 120°C), which were transformed from Rs~1~ and Rs~2~. Many studies have revealed that rare ginsenosides in red ginseng enhanced its bioactivities. As discussed above, changes in the PPD, PPT, OCO, OLE types of ginsenosides in red American ginseng were studied systematically, indicated that the steaming time and temperature were significant and influencing parameters of the processing procedure. Due to the chemical complexity in the variation of ginsenosides compositions, multicomponents should be monitored for critically standardizing the conditions and controlling the quality during red American ginseng process. And the multicomponents quantitative assessment could ensure the therapeutic effects of dried and red American ginseng products.

3.5. Summary of steaming-induced ginsenosides conversion of red American ginseng derived from *Panax quinquefolium* L. {#sec3.5}
----------------------------------------------------------------------------------------------------------------------

To study the chemical conversion during the process of American ginseng, the ginsenosides markers were identified and relatively quantified. The results demonstrated that the chemical transformation occurred under steaming. The transformation pathways of PPD, PPT, OCO, OLE types of ginsenosides are summarized in [Scheme 2](#sch2){ref-type="fig"}, and the content changes of each compound are presented using histograms added beside the corresponding structure. In the [Scheme 2](#sch2){ref-type="fig"}, main and secondary transformation pathways are shown with different sized arrows and the specific structure product ginsenosides are highlighted with gray background. The characteristic transformation mechanisms detected were discussed.Scheme 2Scheme 2. The transformation pathways of four types of ginsenosides. (A) protopanaxadiol; (B) protopanaxatriol; (C) ocotillol; (D) oleanane. OCO, ocotillol; OLE, oleanane; PPD, protopanaxadiol; PPT, protopanaxatriol.Scheme 2

Ginsenosides Rb~1~, Rb~2~, Rb~3~, Rc as original PPD ginsenosides transformed to Rd by the hydrolysis of glycosylation moiety at C-20 terminus, leading the relative peak areas declined. Rd could be hydrolyzed to 20(S)-Rg~3~ with its epimer 20(R)-Rg~3~ and its isomer F~2~ by the loss of glucose residue at C-20 and C-3, respectively. Furthermore, 20(S,R)-Rg~3~ produced 20(S,R)-Rh~2~ through the hydrolysis of glycosylation moiety at C-3 terminus. The 20(21) and △20(22) isomers Rk~1~ and Rg~5~ were generated from 20(S,R)-Rg~3~ through dehydration at C-20. And then, 20(S,R)-Rh~2~, Rk~1~ and Rg~5~ could convert to 20(21) and △20(22) isomers Rk~2~ and Rh~3~. The results demonstrated that the transformation pathways of PPT ginsenosides were similar to those of PPD ginsenosides, as the characteristic conversion shown in [Scheme 2](#sch2){ref-type="fig"}(A) and 2(B). The products were observed involving the glycosylation moiety hydrolysis at C-20 terminus to form 20(S,R)-Rg~2~ and at C-6 to form 20(S,R)-Rh~1~ and 20(21) or △20(22) dehydration at C-20 to yield Rg~6~ and Rg~4~. There is also a specific transformation of PPT ginsenosides, C24 and C-25 hydration, and gave rise to 20(S,R)-Rf~2~. In the published reports, the transformation mechanisms and pathways of PPD and PPT ginsenosides were described during fresh ginseng steaming [@bib8], [@bib9], [@bib11], [@bib27]. And the previous results partially agreed with our findings obtained from American ginseng steaming in related transformation mechanisms. Because of the differences in ginsenoside compositions of ginseng and American ginseng, the transformation pathways were not identical.

For OCO- and OLE-type ginsenosides, the losses of glycosylated substitution were the main chemical transformation pathways. The possible ginsenoside products were deduced and shown in [Scheme 2](#sch2){ref-type="fig"}(C) and 2(D). With regard to OCO- and OLE-type ginsenosides, the chemical transformations have not been systematically studied in American ginseng research to our knowledge.

The malonyl and acetyl ginsenosides released malonic and acetic acid by demalonylation and deacetylation reactions, respectively, to yield their corresponding neutral ginsenosides. Malonyl and acetyl ginsenosides could reportedly convert to neutral ginsenosides and provide the acidic environment to further promote degradation of neutral ginsenosides [@bib10], [@bib11]. Under steaming, acetyl ginsenosides produced their corresponding neutral ginsenosides firstly and subsequently transformed to their corresponding rare ginsenosides with low molecular weight. In our study, the acetyl rare ginsenosides were detected in red American ginseng for the first time, transformed from their corresponding acetyl ginsenosides by hydrolysis of terminus glucosylation moiety and dehydration at C-20. This result demonstrated that acetyl ginsenosides presented two kinds of transformation pathways, which have not been reported yet.

Our results provide related chemical transformation of four types of ginsenosides during American ginseng processing. These ginsenosides generated in steaming of American ginseng may be helpful for evaluating pharmacological effects and bioactive constituents\' definition.

4. Conclusions {#sec4}
==============

In summary, the HPLC-MS^n^-based multicomponent profiling was developed to assess the holistic qualities of dried and red American ginseng. The specific fragments of four major types of ginsenosides were PPD at *m/z* 459, PPT at *m/z* 475, OCO at *m/z* 491, and OLE at *m/z* 455. And the aglycone of chemically-derived ginsenosides produced specific fragments at *m/z* 441 and *m/z* 457 for △20(21)- or △20(22)-dehydrated PPD and △20(21)- or △20(22)-dehydrated PPT, meanwhile *m/z* 493 for 24,25-hydrated PPT were also observed in MS^n^. Based on the characteristic fragmentation pathways of four types ginsenosides, the structure of 59 multiginsenoside components in dried and red American ginseng were analyzed. The chemical markers that could discriminate dried and red American ginsengs were discussed, and the possible transformation mechanisms were summarized. The ginsenosides composition of red American ginseng changed with the increase in the steaming time and temperature. The ginsenosides with higher molecular weight and more polarity converted to the rare ones with lower molecular and less polarity via hydrolysis of saccharides substituents. The malonyl or acetyl ginsenosides transformed to their corresponding neutral ginsenosides and acetyl rare ginsenosides. And the production of 20(R)-ginsenosides epimers, dehydrated, and hydrated ginsenosides were the specific constituents of red American ginseng. The results, discussed above, are definitely helpful for quality assessment and standardizing the processing procedures of red American ginseng. Furthermore, the results also provided a scientific basis for the research on biological compositions, which is responsible for the pharmacological efficacy of red American ginseng and the safe usage of American ginseng in clinic.
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